Prothena(PRTA) - 2020 Q2 - Earnings Call Presentation

Prothena Corporate Overview August 6, 2020 Forward-Looking Statements This overview contains forward-looking statements. These statements relate to, among other things: the sufficiency of our cash position to fund advancement of a broad pipeline; the continued advancement of our discovery and preclinical pipeline; our goal of building a neurotherapeutics engine; the design, proposed mechanism of action and possible clinical benefits of prasinezumab (PRX002/RG7935), and its potential as a treatment for Parki ...